VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

CXCR3

Gene Name CXCR3
Sequence Strain (Species/Organism) Homo sapiens
NCBI Gene ID 2833
NCBI Protein GI 218563730
Genbank Accession AB032735
Protein Accession NP_001136269
Taxonomy ID 9606
Chromosome No X
Gene Starting Position 71615912
Gene Ending Position 71618516
Gene Strand (Orientation) -
Protein Name transcript variant X4
Protein pI 8.31
Protein Weight 42050.08
Protein Length 415
Protein Note Also known as GPR9; MigR; CD182; CD183; Mig-R; CKR-L2; CMKAR3; IP10-R
DNA Sequence 
>NC_000023.11:71615912-71618516 Homo sapiens chromosome X, GRCh38.p12 Primary Assembly
GCCCTGGTCCTGACGATCTTGTTTATTGAAAAGTTTTAAGCAGGATTTTAGACATAAAAATAAAAGAGCA
AATATAGAGGTCTTGGGGACCATGGCCACAGTCACTGCTGAGCTGGAGGCCTGGGCTGTGGCTTCATGGG
GCAGCACCCTCTACGCCATGCCTTGTACTCCCCGCACTTGGGGAAGATGAAGTTTTAGTTTCCAAATGAG
AAGGGCAGTGGGGCTCCAGGCAGCCACCTCGGGCGGCAGGATGGGGCTTGGCAGCTAAGGAGCAGCAATG
GTGCAGTCCTCAGAGCTGGGAGGGTGGCTTCCCGGGAGACCTGGTGGTGCTGGGGCTGCCAGTGAGTCCC
GGGAGCGAGGATATTGGGGAGAGCCAGAGCCGGCAGAGGGAGGGAGGAGCCTGGAATGCGGGGAAGTCAG
ACTGTGGGCGAAAGGGGAGCCCGGATTCCGGCCTCACAAGCCCGAGTAGGAGGCCTCTGAGGTCTCAGAC
CAGGATGAATCCCGGCGGGAAGACGATGGCTGCCTCTGGAGCCCTCTCTGGTTGGGGCAGCCCAGGCGCA
AGAGCAGCATCCACATCCGCTCCCGGAACTTGACCCCTACAAAGGCATAGAGCAGCGGGTTGAGGCAGCA
GTGCATGTAGCCCAGGCCTGAGGTGACCGACTTGGCCACGTCTACCCTGCTTTCTCGGCCACAGTTGCGG
GCCAAAGCGCCCAGGTCCATGAGGATGTCCACCAGCACCACCAGGTGATAGGGGGTCCAGCAGAGGGCAA
AGGCCACCACGACCACCACCACCAGCCGCATGGCCCGCAGGCGCCGCTGGCCCCTGGAAACCAGCAGCAC
GGCCAGGATGTGGGCATAGCAGTAGGCCATGACCAGCAGGGGCAGCAGAAAGCCAGCCACCAGCTGCAGC
ACCCGCAGAGCCGTGCGGCCCACCTGTGGGAAGTTGTATTGGCAGTGGGTGGCGTTGAGGCGCTCGTCGT
GGTGGGCCGACAGGAAGATGAAGTCTGGGAGGGCGAAAAGCAGGCAGAGCCCCCAGACAGCCAGGCAGGT
GAGGGTCACGCGGGCCGGGGGCCCCCGGCGGTAGAGCTGGGTGGCATGAACTATGTTCAGGTAGCGGTCA
AAGCTGATGCAGGCCAGCAGGAGGGCTCCTGCGTAGAAGTTGATGTTGAAGAGGGCACCTGCCACTTTGC
AGAGGCCAGAGCCAAAGACCCACTGGACGGCAGCGTCCACTGCCCAGAGCGGCAGTGTCAGCACCAGCAG
CGTGTCTGCTACAGCTAGGTGGAGCAGGAAGGTGTCGGTGCTGCTCAGGGCTGTCCGCCGGCTCAGCAGC
ACGGCTGCCACCGCGCCGTTGCCCAGCAGCCCCAGCAGAAAGAGGAGGCTGTAGAGGGCTGGCAGGAAGG
CCCGGTCGAAGTTCAGGCTGAAGTCCTGTGGGCAGGGCGGGGAGGTACAGCACGAGTCACTCTCGTTTTC
TCCATAGTCATAGGAAGAGCTGAAGTTCTCCAGGAGGGCGGCAACCTCGGCGTCATTTAGCACTTGGTGG
TCACTCACCTGTGAGGGCGGGAACGGGGAGGAAGGGGCTGTGTAAAGGCCTGGCAGGAACTCTTTTGTGA
TTGAGTCTGATTTAGTCTGTGATTTACTCTGAGCAGCTCCTCCTATAACTGTCCCCGCCAGTCTTCCAGG
GCCGTACTTCCTCAACTCCATCCGCTCAGCCTGGGCTCTGGGATAGTGACTTCCCTTCTCAAAGGCTGCT
TCTCTCGCATTCTTCTGCGTGATCCCATCGGCCCAGGGACCCCTGGGCAGGAAGAAGAGCGTCCCTCCAG
TGCCCAGAGCCCTCTCTGCCCACTGTCCTCTCTCTCCCTGCTCTCCCTTCAGGCTTGCCTTGCGTCCTCA
GTGCCCCACCCCCAACACATAGTTCAACCACCTTCCTCCCCAGCGCCTCTCCACAATCCCCTTTTCCAGT
CACTAACCCTCCTCTTCCCTCCTTGGCCCTTGTCCGGGGACCCCAACTTCCTGCGCCCCCCCCCACCGTG
TGGCCTCTCTACAAGTCACCACGCCCCCCAAATGCATGCAGTCTGCCCAGTCCTTCCCCCTCCCTACACT
GAGGCTTGCACGGCCATTTAGCTGCCCACAAGGGGATCCCCCACTTAGCTTGAGAAGGAATCTTCTTTAT
CCCCTCACCCCCAGCACTATGGACCTGCAGGTCTCCCCAGTACCAATTTAGTCCAGCACGCCAAGAGTCA
AAGTTCCAAGTCTCCTGAAGGGAGCCTTCGAGTCTACTTGCCCCCCGCCCCCCCCATTTTGCAGACGAGA
CACCGAAGCCAGAGAGGAGAGGAGAGGCACCCAGGGTCAGTGGCCAAGCTGGGTTCCCAATTCCCCAGTG
CTGTTTCTGCCACAACCCATGCGGCCTCCAGCTACTCACCCAACCCTGTGGTGACCCTGGGCTGTGGGCC
AGCCCTGGCATTCCCCTGATGCCCCGGGTTTTCCACTTCGAATTCTGGCCTGGCCTGGCTGGGCAGCAGC
ACTTACCTCAAGGACCATGGCTGGGCTGGTGCTCTGGCTGCTGGGTGGTGTGCTGCCTGCCCCTCTGCTT
TGGTGCTTGTGGTTG
Protein Sequence 
>NP_001136269.1 C-X-C chemokine receptor type 3 isoform 2 [Homo sapiens]
MELRKYGPGRLAGTVIGGAAQSKSQTKSDSITKEFLPGLYTAPSSPFPPSQVSDHQVLNDAEVAALLENF
SSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLL
HLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRG
PPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAY
CYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVT
SGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL
Molecule Role Protective antigen
Related Vaccines(s) 2011–2012 trivalent inactivated vaccine (A/California/7/09 (H1N1,), A/Perth /16/2009 (H3N2), and B/Brisbane/60/2008).
References